CAS 82571-53-7|Ozagrel

Introduction：Basic information about CAS 82571-53-7|Ozagrel, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Ozagrel BiologicalActivity
3. Chemical & Physical Properties
4. Safety Information
5. Synonyms

Common Name	Ozagrel
CAS Number	82571-53-7	Molecular Weight	228.247
Density	1.2±0.1 g/cm3	Boiling Point	468.0±25.0 °C at 760 mmHg
Molecular Formula	C₁₃H₁₂N₂O₂	Melting Point	223 - 224ºC
MSDS	/	Flash Point	236.8±23.2 °C

Names

Name	(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
Synonym	More Synonyms

Ozagrel BiologicalActivity

Description	Ozagrel(OKY-046) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.Target: Thromboxane A2 SynthaseOzagrel was selected as the best compound of highly selective inhibitors of TXA2 synthase. The inhibition of TXA2 synthase by ozagrel was more effective on human and rabbit enzymes than those of other species. Ozagrel increased 6-keto-PGF1 alpha, one of stable metabolites of PGI2, in various isolated cells and tissues perhaps via accumulated PG endoperoxides resulted by the inhibition of TXA2 synthase [1]. Ozagrel was estimated to be a reversible mixed-type inhibitor of diphenolase activity with the constants (K (S1), K (S2), K (i1), and K (i2)) determined to be 2.21, 3.89, 0.454, and 0.799 mM, repectively [2]. Infusion of OKY-046 significantly inhibited pulmonary thromboxane B2 delivery, attenuated the early increase in pulmonary vascular resistance, and blocked the increase in systemic vascular resistance. In addition, OKY-046 blunted and delayed the decrease in cardiac output and maintained end-systolic pressure-diameter relation, +dp/dt, and lung lymph flow at baseline values [3].
Related Catalog	Signaling Pathways >>Metabolic Enzyme/Protease >>Factor XaResearch Areas >>Cardiovascular Disease
References	[1]. Nakazawa, M., et al., [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase]. Yakugaku Zasshi, 1994. 114(12): p. 911-33. [2]. Li, S.B., et al., In vitro effect of ozagrel on mushroom tyrosinase. Protein J, 2009. 28(3-4): p. 182-8. [3]. Westphal, M., et al., Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury. Anesthesiology, 2005. 102(5): p. 954-61.

Description

Ozagrel(OKY-046) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.Target: Thromboxane A2 SynthaseOzagrel was selected as the best compound of highly selective inhibitors of TXA2 synthase. The inhibition of TXA2 synthase by ozagrel was more effective on human and rabbit enzymes than those of other species. Ozagrel increased 6-keto-PGF1 alpha, one of stable metabolites of PGI2, in various isolated cells and tissues perhaps via accumulated PG endoperoxides resulted by the inhibition of TXA2 synthase [1]. Ozagrel was estimated to be a reversible mixed-type inhibitor of diphenolase activity with the constants (K (S1), K (S2), K (i1), and K (i2)) determined to be 2.21, 3.89, 0.454, and 0.799 mM, repectively [2]. Infusion of OKY-046 significantly inhibited pulmonary thromboxane B2 delivery, attenuated the early increase in pulmonary vascular resistance, and blocked the increase in systemic vascular resistance. In addition, OKY-046 blunted and delayed the decrease in cardiac output and maintained end-systolic pressure-diameter relation, +dp/dt, and lung lymph flow at baseline values [3].

Related Catalog

Signaling Pathways >>Metabolic Enzyme/Protease >>Factor XaResearch Areas >>Cardiovascular Disease

References

[1]. Nakazawa, M., et al., [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase]. Yakugaku Zasshi, 1994. 114(12): p. 911-33.

[2]. Li, S.B., et al., In vitro effect of ozagrel on mushroom tyrosinase. Protein J, 2009. 28(3-4): p. 182-8.

[3]. Westphal, M., et al., Selective thromboxane A2 synthase inhibition by OKY-046 prevents cardiopulmonary dysfunction after ovine smoke inhalation injury. Anesthesiology, 2005. 102(5): p. 954-61.

Chemical & Physical Properties

Density	1.2±0.1 g/cm3
Boiling Point	468.0±25.0 °C at 760 mmHg
Melting Point	223 - 224ºC
Molecular Formula	C₁₃H₁₂N₂O₂
Molecular Weight	228.247
Flash Point	236.8±23.2 °C
Exact Mass	228.089874
PSA	55.12000
LogP	1.65
Vapour Pressure	0.0±1.2 mmHg at 25°C
Index of Refraction	1.593
InChIKey	SHZKQBHERIJWAO-AATRIKPKSA-N
SMILES	O=C(O)C=Cc1ccc(Cn2ccnc2)cc1

Safety Information

Hazard Codes	Xn,Xi
Risk Phrases	R22:Harmful if swallowed.
Safety Phrases	S36
RIDADR	3249
WGK Germany	3
RTECS	US4025000
Packaging Group	III
Hazard Class	6.1(b)

Synonyms

p-(1-imidazolylmethyl)cinnamic acid

Ozagrelum

2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-

Xanbon

(E)-4-(1-imidazolylmethyl)cinnamic acid

Ozagrel

(E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenic acid

(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoic acid

Cataclot (TN)

2-Propenoic acid,3-(4-(1H-imidazol-1-ylmethyl)phenyl)-,(E)

OKY 046

Ozagrelum [Latin]

MFCD00868231

(E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic Acid

(E)-4-(Imidazol-1-ylmethyl)cinnamic Acid

(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylic acid

Cataclot

(E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylic acid

Ozagrel (INN)

EINECS 242-903-4

Recommended......